Track And Trace Negotiations Continue As Senate Works To Cull Amendments
This article was originally published in The Pink Sheet Daily
Language in manager’s amendment is considered a placeholder, and a resolution could come when the Senate’s FDA user fee bill reaches the conference committee. But first, the bill needs to pass.
You may also be interested in...
Agency meets with USAID stakeholders and wants to maximize the public health impact of its hand-held counterfeit drug detection device, which allows for quick preliminary screening of drug shipments to determine if counterfeit or adulterated product is present.
Sen. Rockefeller introduces amendment that would require 16 hours of training every three years to maintain DEA registration.
Senate health committee defers action on several potentially contentious issues, with members hoping to resolve differences over FDA’s authorities on imports, shortages, foreign data and track-and-trace before the bill goes to the floor, possibly in May. Meanwhile, the House postpones its mark-up in an effort to craft a more bipartisan bill, and now will try to push the user fee package to the floor during an upcoming four-day marathon session.